Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05098132
Title Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Subjects With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Synthekine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center RECRUITING La Jolla California 92093-0698 United States Details
UCLA Hematology/Oncology - Santa Monica RECRUITING Santa Monica California 90404 United States Details
Yale New Haven Hospital, Yale Cancer Center RECRUITING New Haven Connecticut 06510 United States Details
Winship Cancer Institute, Emory University RECRUITING Atlanta Georgia 30322 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Columbia University Irving Medical Center RECRUITING New York New York 10032 United States Details
Memorial Sloan-Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Duke Cancer Center RECRUITING Durham North Carolina 27710 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute - Nashville RECRUITING Nashville Tennessee 37203 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field